Bill and Melinda Gates Foundation donations made to Centers for Disease Control and Prevention

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country
Facebook page CDC
Websitehttp://www.cdc.gov
Twitter usernameCDCgov
Wikipedia pagehttps://en.wikipedia.org/wiki/Centers_for_Disease_Control_and_Prevention
Instagram usernameCDCgov

Full donee page for donee Centers for Disease Control and Prevention

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Global health (filter this donor) 26 34,026,448.75 254,559.00 155,068.00 2,367,845.00 1,626,640.00 5,612,376.00 8,457,644.00 1,124,711.00 5,682,230.00 5,378,457.00 3,266,918.75 100,000.00
Total 26 34,026,448.75 254,559.00 155,068.00 2,367,845.00 1,626,640.00 5,612,376.00 8,457,644.00 1,124,711.00 5,682,230.00 5,378,457.00 3,266,918.75 100,000.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (26 donations)

Amount (current USD)Donation dateCause areaURLInfluencerNotes
254,559.002018-09-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
18,591.002017-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
136,477.002017-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to perform the laboratory analysis for Inactivated Polio Virus (IPV) clinical trials; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
373,358.002016-09-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to perform the laboratory analysis for inactivated polio vaccine (IPV) pre-clinical studies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
154,548.002016-08-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
1,908,550.002016-05-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the lab work related to serum neutralization assays and viral shedding analyses of the samples from clinical trials (comparator trials and phase I and II trials with the investigational vaccine) for the novel Oral Polio Vaccine development prog; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-68,611.002016-04-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify the best immunization policy to support the eradication of polio in the world.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
174,000.002015-11-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct an assessment at WHO regional and HQ levels to identify the best approach for strengthening the WHO regional level data system for routine and measles immunization data; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
74,614.002015-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate genetic stability of Sabin type 2 poliovirus and develop a direct detection algorithm for the detection of poliovirus in stool specimens for application in the new oral polio vaccine clinical development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
268,370.002015-11-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
1,109,656.002015-06-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
4,974,967.002014-10-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to strengthen immunization systems by building capacity of sub-national immunization program staff, thereby reducing the number of mothers and infants who die during and immediately after birth; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: Ethiopia|Uganda.
130,740.002014-09-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify the best immunization policy to support the eradication of polio in the world.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
506,669.002014-06-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
50,000.002013-11-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
4,283,479.002013-11-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to strengthen immunization systems by building capacity of sub-national immunization program staff, thereby reducing the number of mothers and infants who die during and immediately after birth; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: Ethiopia|Uganda.
200,115.002013-10-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to validate a qualitative enzyme-linked immunoassay (EIA) for measurement of poliovirus population immunity in endemic countries and in countries at risk of importation worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,739,487.002013-08-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to achieve global polio eradication by decreasing the threat of polio virus importation and potential transmission in Africa by strengthening routine immunization and increasing the national capacity to detect and respond to polio outbreaks; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
1,184,563.002013-04-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify the best immunization policy to support the eradication of polio in the world.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,124,711.002012-09-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop the strategy for onchocerciasis elimination in Africa building on the roll out of NTD mass drug administration programs; Aid type: Project-type interventions. Affected regions: Africa.
1,682,661.002011-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
3,999,569.002011-11-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to achieve global polio eradication by decreasing the threat of polio virus importation and potential transmission in Africa by strengthening routine immunization and increasing the national capacity to detect and respond to polio outbreaks; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
2,989,588.002010-11-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to measure the public health benefits of integrated NTD programs and to correlate expanded disease-specific indicators with other health outcomes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,388,869.002010-10-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop the strategy for onchocerciasis elimination in Africa building on the roll out of NTD mass drug administration programs; Aid type: Project-type interventions. Affected regions: Africa.
3,266,918.752009-11-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to generate information on the impact of a Japanese encephalitis vaccination program, using a safe, affordable Japanese encephalitis vaccine produced by a developing country manufacturer, and to support expanded use of the vaccine; Aid type: Project-type interventions. Affected regions: Asia.
100,000.002008-10-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a safe and effective polio strain for use in an inactivated vaccine by modifying codon usage patterns in polio strains to control viral mutation rates, lower infectivity, and raise genetic stability.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.